Novo Holdings A/s
Investment Portfolio & 13F Holdings Analysis
About
Novo Holdings A/S is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 31 holdings worth $1.3 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.
AI_NATIVE detailed information: This accession holds the following tickers:[ "MRUS", "EWTX", "INSM", "MQ", "CBLL", "BABA", "ABCL", "FOLD", "ASML", "RXRX", "RCKT", "AVBP", "MIRM", "PHVS", "LNZA", "KYTX", "LXEO", "ZBIO", "FDMT", "BN.TO", null, "IOBT", "VERV", "VRDN", "CRM", "PCVX", "BMRN", "BPMC", "CLDX", "CRNX", "VTI" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 31
- Total Value
- 1314623581
- Accession Number
- 0000950123-25-005753
- Form Type
- 13F-HR
- Manager Name
- Novo-Holdings-As
Data Enrichment
97% identified30 identified1 unidentified
Holdings
31 positions • $1.3B total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
Shares:5.3M
Value:$117.7M
% of Portfolio:9.0% ($117.7M/$1.3B)
Shares:9.7M
Value:$51.1M
% of Portfolio:3.9% ($51.1M/$1.3B)
Shares:1.3M
Value:$42.8M
% of Portfolio:3.3% ($42.8M/$1.3B)
Shares:490.0K
Value:$34.6M
% of Portfolio:2.6% ($34.6M/$1.3B)
Shares:2.3M
Value:$30.3M
% of Portfolio:2.3% ($30.3M/$1.3B)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
|---|---|---|---|---|---|---|
| 1.0M | QoQ 0.00% (-0)YoY NEW(+1.0M) | All Managers (Combined) | $285.4M | 21.7% ($285.4M/$1.3B) | YoY NEW(+$285.4M) | |
| 2.3M | All Managers (Combined) | $122.2M | 9.3% ($122.2M/$1.3B) | |||
| 5.3M | YoY NEW(+5.3M) | All Managers (Combined) | $117.7M | 9.0% ($117.7M/$1.3B) | YoY NEW(+$117.7M) | |
ASML HOLDING NV(ASMLcusipN07059210) | 165.8K | QoQ 0.00% (-0) | All Managers (Combined) | $109.9M | 8.4% ($109.9M/$1.3B) | |
Salesforce, Inc.(CRMcusip79466L302) | 272.8K | All Managers (Combined) | $73.2M | 5.6% ($73.2M/$1.3B) | ||
| 1.5M | All Managers (Combined) | $67.6M | 5.1% ($67.6M/$1.3B) | |||
INSMED Inc(INSMcusip457669307) | 724.7K | All Managers (Combined) | $55.3M | 4.2% ($55.3M/$1.3B) | ||
| 9.7M | YoY NEW(+9.7M) | All Managers (Combined) | $51.1M | 3.9% ($51.1M/$1.3B) | YoY NEW(+$51.1M) | |
| 372.3K | All Managers (Combined) | $49.2M | 3.7% ($49.2M/$1.3B) | |||
| 1.3M | All Managers (Combined) | $42.8M | 3.3% ($42.8M/$1.3B) | |||
| 490.0K | QoQ 0.00% (+0) | All Managers (Combined) | $34.6M | 2.6% ($34.6M/$1.3B) | ||
| 1.9M | All Managers (Combined) | $34.6M | 2.6% ($34.6M/$1.3B) | |||
Vaxcyte, Inc.(PCVXcusip92243G108) | 915.0K | All Managers (Combined) | $34.6M | 2.6% ($34.6M/$1.3B) | ||
Merus N.V.(MRUScusipN5749R100) | 789.1K | YoY NEW(+789.1K) | All Managers (Combined) | $33.2M | 2.5% ($33.2M/$1.3B) | YoY NEW(+$33.2M) |
| 2.3M | All Managers (Combined) | $30.3M | 2.3% ($30.3M/$1.3B) | |||
Pharvaris N.V.(PHVScusipN69605108) | 1.7M | All Managers (Combined) | $27.1M | 2.1% ($27.1M/$1.3B) | ||
| 2.8M | All Managers (Combined) | $22.4M | 1.7% ($22.4M/$1.3B) | |||
| 1.2M | YoY NEW(+1.2M) | All Managers (Combined) | $21.8M | 1.7% ($21.8M/$1.3B) | YoY NEW(+$21.8M) | |
| 228.8K | All Managers (Combined) | $20.3M | 1.5% ($20.3M/$1.3B) | |||
| 2.2M | YoY NEW(+2.2M) | All Managers (Combined) | $17.5M | 1.3% ($17.5M/$1.3B) | YoY NEW(+$17.5M) |